Hallal David

CIK 00014574775 companiesBERKELEY HEIGHTS, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001457477

Recent Transactions

50 trades

Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2026-06-03+9,000→ 9,000 total
Sale
Scholar Rock Holding Corp$SRRK
Common Stock
2026-04-16$49.57/sh−30,615→ 1,639,034 total
Award
Scholar Rock Holding Corp$SRRK
Common Stock
2026-02-09+128,004→ 1,669,649 total
Gift
Scholar Rock Holding Corp$SRRK
Common Stock
2025-10-08−205,000→ 1,599,095 total
Disposition to Issuer
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2025-08-29−146,160→ 0 total
Disposition to Issuer
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2025-08-29−25,140→ 0 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2025-06-06$10.24/sh−38,228→ 0 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2025-06-06−38,228→ 0 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Common Stock
2025-06-06$4.30/sh+38,228→ 38,228 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Common Stock
2025-06-05$4.30/sh+38,227→ 38,227 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2025-06-05−38,227→ 38,228 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2025-06-05$10.15/sh−38,227→ 0 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Common Stock
2025-06-04$4.30/sh+38,227→ 38,227 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2025-06-04−38,227→ 76,455 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2025-06-04$10.07/sh−38,227→ 0 total
Award
Scholar Rock Holding Corp$SRRK
Stock Option (Right to Buy)
2025-05-02+275,167→ 275,167 total
Award
Scholar Rock Holding Corp$SRRK
Common Stock
2025-04-27+1,250,000→ 1,804,095 total
Award
Scholar Rock Holding Corp$SRRK
Common Stock
2025-04-27+250,000→ 554,095 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2025-04-10+18,000→ 18,000 total
Award
Scholar Rock Holding Corp$SRRK
Common Stock
2024-06-27+13,500→ 304,095 total
Award
Scholar Rock Holding Corp$SRRK
Stock Option (Right to Buy)
2024-06-27+18,000→ 18,000 total
Award
Seer, Inc.$SEER
Class A Common Stock
2024-06-12+58,178→ 355,128 total
Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2024-06-11+24,200→ 24,200 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-06-06+35,000→ 2,143,662 total
Award
Scholar Rock Holding Corp$SRRK
Stock Option (Right to Buy)
2023-06-21+36,000→ 36,000 total
Award
Seer, Inc.$SEER
Stock Option (right to buy)
2023-06-14+34,735→ 34,735 total
Award
Seer, Inc.$SEER
Class A Common Stock
2023-06-14+23,443→ 296,950 total
Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2023-06-13+22,383→ 22,383 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-05-11+35,000→ 2,108,662 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-10-19$8.45/sh−600,000→ 138,153 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-09-29$7.35/sh−400,000→ 720,965 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-07-28$4.61/sh+3,253,796→ 16,674,766 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-07-21$5.33/sh−4,227→ 2,073,662 total
Award
Scholar Rock Holding Corp$SRRK
Stock Option (Right to Buy)
2022-06-16+14,000→ 14,000 total
Award
Seer, Inc.$SEER
Class A Common Stock
2022-06-15+9,945→ 273,507 total
Award
Seer, Inc.$SEER
Stock Option (right to buy)
2022-06-15+29,640→ 29,640 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Common Stock
2022-06-09$4.23/sh+1,171→ 1,171 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-09−1,171→ 146,160 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2022-06-09$19.51/sh−1,171→ 0 total
Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-09+17,538→ 17,538 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-08−5,968→ 157,908 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-08−11,899→ 25,140 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Common Stock
2022-06-08$4.23/sh+10,577→ 10,577 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2022-06-08$20.39/sh−11,899→ 0 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2022-06-08$20.39/sh−5,968→ 0 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2022-06-08$19.86/sh−10,577→ 0 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Common Stock
2022-06-08$2.95/sh+11,899→ 11,899 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-08−10,577→ 147,331 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Common Stock
2022-06-08$4.23/sh+5,968→ 5,968 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-06-03$3.67/sh−65,725→ 2,077,889 total

Companies

Recent Filings

Address

C/O KALARIS THERAPEUTICS, INC. 400 CONNELL DRIVE, SUITE 5500

BERKELEY HEIGHTS, NJ, 07922

View on SEC.gov